Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

June 07, 2024 00:22:24
Episode Cover

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at...

Listen

Episode 0

July 21, 2019 00:19:47
Episode Cover

Critically Ill Patients with Vibrio Infection

With increasing water temperatures, there is a rise in the incidence of V.vulnificus infections in non-endemic regions.  Patients with V.vulnificus infection are often critically...

Listen

Episode 0

November 15, 2021 00:28:29
Episode Cover

Hyperkalemia in the ED

Hyperkalemia is a life-threatening electrolyte disorder that is commonly encountered in the ED and ICU.  In this podcast we review the latest evidence in...

Listen